NeuroproteXeon, a company in which Inspiration Healthcare owns 8.1% (fully diluted), has announced a distribution agreement with Linde for its pipeline asset Xenex. The agreement includes up to €23m in milestone payments plus royalties on sales and follows a similar agreement with Mallinckrodt announced in October 2017. The two deals in aggregate amount to ~£46m in upfront and milestone payments with royalties paid on future product sales. We maintain our Buy recommendation on Inspiration Health ....
10 May 2018
Investment signs 2nd agreement
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Investment signs 2nd agreement
Inspiration Healthcare Group PLC (IHC:LON) | 28.5 0 0.0% | Mkt Cap: 19.4m
- Published:
10 May 2018 -
Author:
Chris Donnellan -
Pages:
6
NeuroproteXeon, a company in which Inspiration Healthcare owns 8.1% (fully diluted), has announced a distribution agreement with Linde for its pipeline asset Xenex. The agreement includes up to €23m in milestone payments plus royalties on sales and follows a similar agreement with Mallinckrodt announced in October 2017. The two deals in aggregate amount to ~£46m in upfront and milestone payments with royalties paid on future product sales. We maintain our Buy recommendation on Inspiration Health ....